Abstract, Human fibroblasts have a limited replicative life span when maintained in culture after which they become unresponsive to treatment with mitogens, a phenomenon most commonly called senescence. Experiments indicating that serum does not induce expression of the c-fos proto-oncogene in senescent fibroblasts raised the issue of a potential central role for c-fos in the phenotype of sustained growth arrest. This was directly tested by microinjection of oncogenic c-Ha-ms protein into senescent fibroblasts. While ras injection was found to induce marked nuclear c-fos expression and functional AP-1 transcription activity, this did not lead to DNA synthesis. These results suggest that the senescence phenotype cannot be solely attributed to the absence of c-fos expression and that the proliferative block in these cells is either independent of AP-1 transcriptional activity, downstream of it, or involves multiple molecular mechanisms.
which can acquire oncogenic characteristics by point mutations at discrete locations in their coding sequences (Tabin et al., 1982) , or by overexpression (Wigler et al., 1984) . Microinjection of oncogenic ras protein into quiescent fibroblasts has been shown to result in changes in cell morphology (Feramisco et al., 1984) , induction of c-fos expression (Stacey et al., 1987) , and initiation of DNA synthesis. In contrast, senescent human fibroblasts injected with oncogenic c-Ha-ms expression vectors (Lumpkin et al., 1986) fail to synthesize DNA. Transformation of cycling or quiescent fibroblasts by microinjected Ha-ras proteins proceeds temporally, with stimulation of membrane ruffling and pinocytosis within 30-90 min postinjection, induction of c-fos expression within 1-2 h, and increased DNA synthesis within 24 h. We sought to determine which identifiable components of the oncogenic ras proliferative program were active in senescent human fibroblasts.
Materials and Methods

Cell Culture
Human fetal lung fibroblasts (IMR-90 cells) were maintained at 37~ in a humidified incubator under a 5% CO2 atmosphere in DME/high glucose (Gibeo Laboratories, Grand Island, NY) supplemented with 10% FBS (Gemini Bioproducts, Inc., Caiabasas, CA) and penicillin/streptomycin. Senescent cells were generated from late passage human fetal lung fibroblasts, IMR-90 cells, which became nonproliferative after 47-55 population doublings during serial passage in vitro (Adler et al., 1991) . Typically 5-7 % of these cells were capable of DNA synthesis as compared to '~ % of early passage cells defined by <20 population doublings. An additional operational criterion for senescence was that the cells could not grow to confluence 4 wk after their final passage. Cells were grown initially on plastic dishes and were then prepared for microinjection by trypsinization and replating on sterile glass acid-washed coverslips at subconfluent density. Before injection, early passage and senescent fibroblasts were plated separately at equal density and rendered quiescent by incubation in DME supplemented with 0.5% serum for at least 36 h. Under these conditions, the proliferating fraction in both early and late passage cultures was <7%.
Microinjection
The following samples and concentrations were used in microinjection experiments: oncogenic "1"-24 ras protein, at a final concentration of "01.0 mg/ml, resulting in the introduction of 10~-106 molecules per cytoplasmically injected cell. The ras protein was purified from an F~cherichia coli expression vector system (Gross et al., 1985) to near homogeneity as in Feramisco et al. (1984) . Inert carrier IgG (Sigma Chemical Co., St. Louis, MO) was coinjected with all samples at a concentration of 2 mg/ml to allow the definitive identification of all microinjected cells. The coinjected IgG used was either murine or rabbit depending upon the particular experiment. Control injections of carrier IgG alone were carried out in all cases and were found not to affect any of the assays described below. In experiments involving the use of expression vectors, the purified 4XTRE/IacZ plasmid or the 5XCRE/lacZ plasmid (Meinkoth et al., 1990 ) were used at a final concentration of 0.5 mg/ml and nuclear microinjections were performed. In these cases, smaller amounts of protein were injected into the nuclei, however, some spillover into the cytoplasm was routinely observed.
Samples were microinjected into IMR-90 cells at room temperature using an Eppendorf microinjector (model 5242, Brinkman Instruments Inc., Westbury, NY) attached to an Eppendorf micromanipulator (model 5170 or 5171) and an inverted microscope (Carl Zeiss, Oberkochen, Germany). Samples were loaded into Eppendorf Femtotips using Microloader pipette tips. Injections were performed with a typical needle pressure of "0120 hPa for cytoplasmic injections and about 75 hPa for nuclear injections.
Staining and Fluorescence Microscopy
To examine morphological effects of oncogenic ms protein microinjection, early passage and senescent IMR-90 cells were injected with either murine IgG alone or with IgG and T-24 ms. After 3 h of incubation at 37"C, the cells were fixed for 30 min in 95 % ethanol, 5 % acetic acid and then stained to visualize the distribution of coinjected IgG. Microinjected murine IgG was detected using HRP-conjngated rabbit anti-mouse IgG (Amersham Corp., Arlington Heights, IL) followed by 3,3' diaminobenzidine tetrahydrochloride as substrate. Coverslips were permanently mounted on glass microscope slides for analysis.
To quantitate DNA synthesis in injected cells, a solution of 5-bromo-2'-deoxyuridine (BrdU) l (Amersham Corp., cell proliferation kit) was added to the culture medium for 24 h after microinjection. After labeling, coverslips were washed in PBS, and the cells were then fixed in 3.7 % formaldehyde in PBS and incubated with a monoclonal rat antibody against BrdU (Accurate Chemical and Scientific Corp., Westbury, NY). The antibody was diluted in a solution of 0.5% NP-40 in PBS containing 1,000 units/ml of DNAse I (Sigma Chemical Co.), 10 mM MgCI2, and 5 mg/ml BSA. Staining was visualized using rhodamine-conjugated donkey anti-rat IgG (Jackson Immunoresearch Laboratories, Inc., West Grove, PA). Microinjected cells were detected by staining with a fluorescein isothiocyanateconjugated horse anti-rabbit IgG (Cappel Laboratories, Cochranville, PA). Expression of c-fos protein was detected by staining with a polyclonai antibody to human c-fos (Oncogene Science, Inc., Manhasset, NY) followed by sequential use of biotinylated horse anti-rabbit IgG (Vector Laboratories, Burlingame, CA) and streptavidin-conjugated Texas red (Amersham Corp.). The anti-fos antibody is specific for c-fos and other fos family members.
In experiments measuring transcriptional activity from microinjected reporter plasmids, nuclei of IMR-90 cells were injected with mixtures of carrier IgG and the appropriate expression vector either in the absence or presence of T-24 ms protein. To test for the presence of AP-1 (los dependent) transcriptional activity, the 4XTRE/lacZ construct (Meinkoth et al., 1990) was used. As a control, the 5XCRE/IacZ expression vector was microinjected in parallel. 6 h after injection, cells were fixed and stained overnight with the chromogenic substrate 5-bromo-4-chloro-3-indolyl-/~-D-galactoside (Xgal) to detect/3 galactosidase expression. To insure the activity of the vector, duplicate injections of the 5XCRE/IacZ plasmid were performed, and the cells were treated with 1 mM 8-bromo-cAMP and 1 mM isobutylmethylxanthine for 3 h before staining. In all cases, injected cells were detected by staining with fluorescein isothiocyanate-conjugated rabbit anti-mouse IgG (Cappel Laboratories). All injection experiments described were performed a minimum of three separate times. Cells were viewed and results analyzed on an Axiophot epifluorescence microscope (Carl Zeiss) equipped with fluorescein and rhodamine fluorescence filters. Photomicrographs were taken on Technical Plan 100 film (phase contrast) or T-Max 400 film for fluorescence (Eastman Kodak Co., Rochester, NY).
Results
ras-lnduced Morphological Changes
Microinjection of T-24 ras protein into senescent fibroblasts resulted in membrane-associated morphological changes within a short period of time, which became obvious with immunohistochemical staining within 2-4 h (Fig. 1) . Increased membrane ruffling, closely associated with pinocytosis, has been shown previously to be an integral part of the ms-induced proliferative process (Bar-Sagi and Feramisco, 1986). Similar cell surface ruffling and fluid-phase pinocytosis, although less distinct and sustained, occur before the mitogenic effect of serum or purified growth factors upon cells maintained in serum-free medium (Myrdal and Auersperg, 1986). The majority of ras protein-injected cells exhibited grossly observable cytoplasmic vacuolation. Senescent cells which were injected with carrier IgG alone for comparison purposes did not exhibit observable effects from the microinjection process (Fig. 1) . These cell surface changes seen in senescent fibroblasts injected with T-24 ras protein provided evidence that at least some of the early 1. Abbreviations used in this paper: BrdU, 5-bromo-2'-deoxyuridine; Xgal, 5-bromo-4-chloro-3-indolyl-/~-o-galactoside. components of the proliferative process were intact, and that the block in proliferation was therefore either independent of these phenotypic changes or downstream of them. In addition, the morphological changes demonstrated the biological activity of the ms protein in this cell line. This observation raised the question of whether ms-mediated induction of c-fos expression, observed in quiescent presenescent fibroblasts, also occurs in senescent cells.
ras-Induced fos Protein Expression
To evaluate the expression of c-fos after the injection of oncogenic ms protein, senescent fibroblasts were injected with ras protein and subsequently were stained simultaneously for the presence of coinjected carrier IgG and for the presence of c-fos protein in the nucleus of injected cells. The use of two different fluorescent probes allowed simultaneous detection of injected cells and c-fos expression in those individual cells (Fig. 2) . In addition, a parallel set of microinjected cells were processed for the incorporation of the thymidine analog BrdU to identify cells which entered S phase of the cell cycle. The results demonstrated (Table I) that the majority of the serum-starved early passage fibroblasts synthesized DNA after ms injection whereas only a rare cell in senescent populations was found to incorporate BrdU. Unexpectedly, injected ms protein induced a strong positive signal for c-los in the majority of nuclei in both presenescent and senescent fibroblasts (Fig. 2) . Because the majority of ms-injected senescent cells expressed c-fos pro-'tein while few cells synthesized DNA under the same conditions, it appears clear that expression of c-fos in these cells was not sufficient to stimulate DNA synthesis.
AP-1 Dependent Gene Expression in Senescent Cells
Because members of the c-fos family form complexes with members of the c-jun family, constituting the family of transacting transcription factors, AP-1, it was of importance to attempt to determine if senescent ceils injected with the ras oncogene protein contained functional AP-1 transcription factor. This may be of particular importance in senescent cells, because AP-1 is known to play a role in the transcriptional regulation of a variety of cellular genes, many of which are subject to control by signals for growth or transformation (Lee et al., 1987a,b; Piette and Yaniv, 1987; Angel et ai., 1987; Franza et al., 1988) . To test this possibility, reporter constructs containing the E. coli lac-Z gene fused to promoters containing either AP-1 (TRE), or cAMP-responsive (CRE), regulatory sequences (Meinkoth et al., 1990; were assayed for expression of #-galactosidase in the senescent cells after coinjection with the ras protein or control protein. Previous studies demonstrated that microinjection of the ms protein into cell lines stably transfected with these reporter genes induces B-galactosidase expression from promoters containing AP-1 binding sites but not CRE sequences (D. Rose, manuscript in preparation). While it has not been directly proven that the injected ras protein activates transcription of the AP-1 regulated reporter gene via a functional AP-I protein complex containing fos and jun, it is likely that this is indeed the case (Chiu et al., 1988) . Thus, these experiments would test whether or not senescent cells were capable of showing enhanced transcription of an AP-1 reporter construct after oncogenic ras injection. Both presenescent and senescent cells coinjected with ras protein and the TRE-lac Z plasmid exhibited efficient 1~ gaiactosidase expression (Fig. 3) . The cells expressed detectable/3-gaiactosidase as early as 3 h postinjection, and required active ms protein in addition to the construct for this expression. In Figure 2 . Expression of c-fos in ras-injected senescent fibroblasts in the absence of DNA synthesis. Microinjection was carried out as in Fig. 1 . Shown are phase contrast contrast, neither type of cell expressed the marker enzyme when the CRE-lacZ reporter construct was coinjected with ras protein. The activity of the CRE-IacZ plasmid was confirmed by duplicate microinjections followed by treatment of the cells with 8-bromo-cAMP and isobutylmethylxanthine (Table II) . These results suggested that while senescent cells injected with the ras protein show enhanced AP-1 dependent gene expression, not all types of transcription factors (i.e., cAMP response element binding protein) are thus activated.
The results document the presence in senescent cells of active AP-1 transcriptional activity specific for a TRE-containing regulatory element in response to oncogenic ras protein microinjection. Thus, while this activity has recently been shown to be decreased in mitogen-stimulated human fibroblasts as the cells age (Riabowol et al., 1992) , injection of ras protein appears to generate a sufficient amount of active AP-1 to give rise to reporter activity.
Discussion
Evidence for a causative role of c-fos in the senescent phenotype has been, to date, the observation of a deficit of its expression in senescent cells. Considering the potential importance of this possibility, we sought a direct experimental approach to test the role of c-fos by attempting to induce the expression of the protein in an intact cellular context 9 Using an assay which permits examination of effects upon individual cells, we have investigated the role ofc-fos in senescent cell growth control. Expression of the c-fos protooncogene is an essential prerequisite for the initiation of DNA synthesis m qmescent fibroblasts stimulated with serum. Senescent human fibroblasts do not express c-fos, however, in response to serum treatment (Seshadri and Campisi, 1990) , despite the observation that these cells appear to express and regulate a number of other genes in a manner typical of fibroblasts. If the observed repression of c-fos expression were the primary defect in senescent cells, one would anticipate that its expression would restore the proliferative potential of the cells, particularly in the presence of a strong replicative signal such as oncogenic ms. The present results, expression of c-fos protein in the absence of DNA synthesis, appear to indicate that this is not the case. Recent results obtained by others (Surmacz et al., submitted for publication) lead to a similar conclusion. Moreover, the present results appear to indicate that while senescent cells are capable of enhanced expression of indicator constructs regulated by AP-1 promoter sequences when they are coinjected with oncogenic ras protein, this increased activity, presumably a downstream effect of increased c-fos expression (Schonthal et al., 1988) is not sufficient to alleviate the block in the cell cycle of senescent cells. Thus, c-fos expression is likely to be necessary but not sufficient for the proliferation of these cells (Surmacz et al., submitted for publication) 9 These results support the view that senescent cells do not fail to proliferate because of an inherent inability to transduce these early stimulatory signals for growth. Senescent cells possess apparently normal growth factor receptors (Goldstein and Shmookler Reis, 1985) 9 The generation of transcriptionally active AP-1 following injection of oncogenic ras protein into senescent ceils indicates that at least some of the intracellular signaling pathways are operative. It is still possible that the arrest to growth in senescent cells is due to the selective repression of one or several normal responses to signals for growth. Microinjection of oncogenic ras protein apparently provides a positive signal of sufficient intensity to overcome the repression of c-fos. This result is of interest in and of itself in view of the general lack of induction of c-fos expression by serum. One possible explanation for this is that injected ras oncogene proteins, which cause an exaggerated ruffling response in comparison to the response seen for serum treatment, overcome a putative block in the normal signaling process associated with the growth factor receptors in the plasma membrane. As it appears that purified mitogens may also induce c-fos expression to some extent in senescent cells (Paulsson et al., 1986) , this possibility seems plausible 9
Another potential underlying mechanism in senescence involves the regulation of the retinoblastoma susceptibility gene product (Rb). The Rb protein is thought to function in a growth-inhibitory manner in normal cells. It is found in a hypophosphorylated state in quiescent cells, and it is thought that traversion of the G1/S cell cycle boundary, allowing DNA synthesis to occur, is dependent upon the hyperphosphorylation of the protein (Mihara et al., 1989) . In senescent cells, this phosphorylation does not occur (Stein et al., 1990) 9 Additionally, SV40 T antigen, which preferentially binds to and is thought to inactivate the hypophosphorylated form of the Rb protein, also induces DNA synthesis when introduced into senescent cells (Wright et al., 1989; Radna et al., 1989) and induces c-fos expression (Surmacz et al. submitted for publication) 9 In the 5' promoter region of the c-fos gene, a negative-acting Rb response element has recently been identified (Robbins et al., 1990) . It is not currently known whether the phosphorylation state of the Rb protein has any effect upon its ability to influence the expression of the c-fos gene, or whether such a mechanism is operative during senescence. We are currently in the process of evaluating the regulation of the Rb protein in response to microinjection of oncogenic ras protein. It is clear, however, from results presented here that if in fact the phosphorylation state of the Rb protein is a determining factor in the lack of progression from G1 to S phase in senescent cells, it appears not to be the mechanism responsible for repression of c-fos expression. Because microinjection of ras protein affects c-fos protein expression but not DNA synthesis, the two events appear to be independently regulated. Events downstream or parallel to c-fos expression deserve particular attention in future efforts to explain the molecular nature of the senescent state. 
